BWLSA
SONX

Blue Water Life Science Advisors’s Sonendo, Inc. SONX Stock Holding History

Blue Water Life Science Advisors’s Portfolio SONX Stock Details SONX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,643,461
Closed -$3.46M – 10
2023
Q3 		$3.46M Hold
4,643,461
– – 3.27% 7
2023
Q2 		$6.32M Hold
4,643,461
– – 4.26% 7
2023
Q1 		$9.29M Hold
4,643,461
– – 6.14% 8
2022
Q4 		$13.1M Buy
+4,643,461
New +$8.75M 8.83% 7

Other funds holding SONX

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Blue Water Life Science Advisors's SONX Position: Q4 2023 in Review

Blue Water Life Science Advisors sold out of Sonendo, Inc. (SONX) in Q4 2023, closing a stake of 4,643,461 shares — an estimated $3.46M sold.

Blue Water Life Science Advisors first reported a position in SONX in Q4 2022 and held it in 4 quarters. The position peaked at $13.1M in Q4 2022. 6 funds tracked by Wall St. Rank hold SONX as of Q4 2023.

  • Blue Water Life Science Advisors reported no remaining Sonendo, Inc. position as of Q4 2023 after selling out during the quarter.
  • Blue Water Life Science Advisors sold 4,643,461 Sonendo, Inc. shares in Q4 2023, an estimated $3.46M.
  • Blue Water Life Science Advisors first reported a position in Sonendo, Inc. in Q4 2022 and held it in 4 quarters.
  • Blue Water Life Science Advisors's Sonendo, Inc. position peaked at $13.1M in Q4 2022.
  • 6 funds tracked by Wall St. Rank held Sonendo, Inc. as of Q4 2023.

Based on Blue Water Life Science Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.